illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Senzime
Company logo

Senzime | Sustainability Performance

https://www.senzime.com/en
Linkedin

Provides monitoring and diagnostic systems for anesthesia and critical care, offering digital platforms that support clinicians in patient management.

1999

Sweden

51 - 200 employees

Medical Device

$10M - 25M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2932
Overall
#192
in Sweden
#41
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Moberg Pharma

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
Recipharm

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
RaySafe

Sweden, Hospital & Health Care, Medical Device

Market cap

4.4B $, 2026▼125.8% YoY

Revenue

10.6M $, 2025▲44.2% YoY

R&D intensity

21.15% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

4.4B $, 2026▼125.8% YoY

Revenue

10.6M $, FY2025▲44.2% YoY

EBITDA

-12.4M $, FY2025▼9.1% YoY

Operating margin

-118% Industry: -136▼80% YoY

Revenue & EBITDA

$10.6MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-13.0M 2025▲0.7% YoY

Capex

1.8M 2025▼11.1% YoY

Debt/equity ratio

0.1 Industry: 1▼NaN% YoY

R&D intensity

21.1%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-43.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 7.8%

2023

0.0

▼ 9.6%

2024

0.0

▲ 0.2%

2025

0.3

2028

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Not available

23%
Independent Directors

3 out of 13 incl. management

Powered by illuminem

Overall score

35

Environment

24

Social

54

Governance

27

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email